References
- VestboJHurdSSRodriguez-RoisinRThe 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) – why and what?Clin Respir J20126420821422906068
- BarberàJARocaJFerrerAMechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary diseaseEur Respir J1997106128512919192930
- Rodríguez-RoisinRDrakulovicMRodríguezDARocaJBarberàJAWagnerPDVentilation-perfusion imbalance and chronic obstructive pulmonary disease staging severityJ Appl Physiol (1985)200910661902190819372303
- WestJBState of the art: ventilation-perfusion relationshipsAm Rev Respir Dis19771165919943921067
- MarthanRCastaingYManierGGuenardHGas exchange alterations in patients with chronic obstructive lung diseaseChest19858744704753979134
- HajianBDe BackerJVosWVan HolsbekeCClukersJDe BackerWFunctional respiratory imaging (FRI) for optimizing therapy development and patient careExpert Rev Respir Med201610219320626731531
- HajianBDe BackerJVosWPulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertensionInt J Chron Obstruct Pulmon Dis2016111533154127462149
- HajianBDe BackerJVosWAertsJCluckersJDe BackerWEfficacy of inhaled medications in asthma and COPD related to disease severityExpert Opin Drug Deliv2016131719172727292454
- De BackerWVosWVan HolsbekeCThe effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patientsEur Respir J201444252752924791831
- BurgelPRBourdinAChanezPUpdate on the roles of distal airways in COPDEur Respir Rev20112011972221357888
- BurgelPRde BlicJChanezPUpdate on the roles of distal airways in asthmaEur Respir Rev200918112809520956128
- HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
- RichardsonATolleyEHartmannJEvaluation of chronic obstructive pulmonary disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?Respir Med201611913514027692135
- NewtonMFO’DonnellDEForkertLResponse of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflationChest200212141042105011948031
- Garcia-RioFLoresVMedianoODaily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflationAm J Respir Crit Care Med2009180650651219542481
- O’DonnellDEBertleyJCChauLKWebbKAQualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanismsAm J Respir Crit Care Med199715511091159001298
- De BackerJVosWVinchurkarSThe effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imagingJ Aerosol Med Pulm Drug Deliv2015282889925004168
- GoldmanMDSaadehCRossDClinical applications of forced oscillation to assess peripheral airway functionRespir Physiol Neurobiol20051481–217919415990365
- VerbanckSSchuermansDMeysmanMPaivaMVinckenWNoninvasive assessment of airway alterations in smokers: the small airways revisitedAm J Respir Crit Care Med2004170441441915130906
- De BackerJWVosWGVinchurkarSCValidation of computational fluid dynamics in CT-based airway models with SPECT/CTRadiology2010257385486221084417
- VinchurkarSBackerLDVosWHolsbekeCVBackerJDBackerWDA case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: effect of upper airway morphology and comparison with in vivo dataInhal Toxicol2012242818822260527
- De BackerLAVosWDe BackerJVan HolsbekeCVinchurkarSDe BackerWThe acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function studyEur Respir J201240229830522183484
- De BackerLAVosWGSalgadoRFunctional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPDInt J Chron Obstruct Pulmon Dis2011663764622162649
- De BackerJVosWVan HolsbekeCEffect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patientsInt J Chron Obstruct Pulmon Dis2013856957924293993
- De BackerLVosWDieriksBThe effects of long-term noninvasive ventilation in hypercapnic COPD patients: a randomized controlled pilot studyInt J Chron Obstruct Pulmon Dis2011661562422135493
- De BackerWDevolderAPoliGLung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patientsJ Aerosol Med Pulm Drug Deliv201023313714820109122
- VosWHajianBDe BackerJFunctional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMAInt J Chron Obstruct Pulmon Dis20161126327126917956
- De BackerJWVosWGDevolderAComputational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilationJ Biomech200841110611317698073
- YanaiMSekizawaKOhruiTSasakiHTakishimaTSite of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressureJ Appl Physiol1992723101610231568955
- LeachCColiceGLLuskinAParticle size of inhaled corticosteroids: does it matter?J Allergy Clin Immunol20091246 SupplS88S9319962042
- CalverleyPMRabeKFGoehringUMRoflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsLancet2009374969168569419716960
- FabbriLMCalverleyPMIzquierdo-AlonsoJLRoflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trialsLancet2009374969169570319716961
- SantosSPeinadoVIRamirezJCharacterization of pulmonary vascular remodelling in smokers and patients with mild COPDEur Respir J200219463263811998991
- MageeFWrightJLWiggsBRParéPDHoggJCPulmonary vascular structure and function in chronic obstructive pulmonary diseaseThorax19884331831893406902